Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease
Year: 2023
Type: article
Abstract: Missense mutations in the uromodulin ( UMOD ) gene cause autosomal dominant tubulointerstitial kidney disease (ADTKD), one of the most common monogenic kidney diseases. The unknown impact of the allelic and gene dosage effects and fate of mutant uromodulin leaves open the gap between postulated gain‐of‐function mutations, end‐organ damage and disease progression in ADTKD. Based on two prevalent missense UMOD mutations with divergent disease progression, we generated Umod C171Y and Umod R186S knock‐in mice that showed strong allelic and gene dosage effects on uromodulin aggregates and activation of ER stress and unfolded protein and immune responses, leading to variable kidney damage. Deletion of the wild‐type Umod allele in heterozygous Umod R186S mice increased the formation of uromodulin aggregates and ER stress. Studies in kidney tubular cells confirmed differences in uromodulin aggregates, with activation of mutation‐specific quality control and clearance mechanisms. Enhancement of autophagy by starvation and mTORC1 inhibition decreased uromodulin aggregates. These studies substantiate the role of toxic aggregates as driving progression of ADTKD‐ UMOD , relevant for therapeutic strategies to improve clearance of mutant uromodulin.
Source: EMBO Molecular Medicine
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: uromodulin, UMOD gene, autosomal dominant tubulointerstitial kidney disease, missense mutations, protein aggregation, allelic effects, gene dosage, endoplasmic reticulum stress, unfolded protein response, autophagy, mTORC1 inhibition, gain-of-function mutations, knock-in mice, renal tubular epithelial cells, disease progression
Open Access status: gold
Estimated APC paid: $5,740
Funders: National Science Foundation, Kidney Research UK, European Commission, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Eidgenössische Technische Hochschule Zürich, Ministero della Salute, Stavros Niarchos Foundation, Universität Zürich, European Rare Kidney Disease Reference Network, Horizon 2020 Framework Programme, Medical Research Council
Awards: G1860250122, G196206291, G2605131367, G2635107535, G2836666931, G3279298100, Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery, G3328826741, G3353396442, G3517776200, G434337789, Uromodulin: from physiology to genetic susceptibility to disease, New genes, modifiers and personalized cell systems in autosomal dominant tubulointerstitial kidney disease, G6158465680, G665935657, G7174794431, G8542473229, Exploring antisense oligonucleotide therapies in autosomal dominant tubulointerstitial kidney disease due to UMOD mutations, G8690818240, Rare Disease Research Platform: The renal ciliopathies national network (RCNN)
OpenAlex ID: W4387965871
